Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
Haematologica|October 24, 2024
Pathogenesis and inflammaging in myelodysplastic syndromeMatthew T Villaume, Michael R SavonaHaematologica|August 18, 2022
Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromesMelissa A Fischer, Yuanbin Song, Maria P Arrate, et al.Leukemia Research|June 17, 2014
Are we altering the natural history of primary myelofibrosis?Michael R SavonaThe Journal of Community and Supportive Oncology|June 28, 2014
Molecular monitoring and minimal residual disease in the management of chronic myelogenous leukemiaMichael R SavonaActa Haematologica|August 17, 2013
Identifying the time to change BCR-ABL inhibitor therapy in patients with chronic myeloid leukemiaMichael R Savona, Giuseppe SaglioCancer Discovery|July 3, 2019
Mitochondrial Homeostasis in AML and Gasping for Response in Resistance to BCL2 BlockadeMichael R Savona, Jeffrey C RathmellCancer Journal (Sudbury, Mass.)|April 9, 2008
Erythropoietin-stimulating agents in oncologyMichael R Savona, Samuel M SilverCurrent Hematologic Malignancy Reports|October 7, 2017
Therapy for Chronic Myelomonocytic Leukemia in a New EraTamara K Moyo, Michael R SavonaCurrent Hematologic Malignancy Reports|October 14, 2016
Molecular Testing in Patients with Suspected Myelodysplastic SyndromesTamara K Moyo, Michael R SavonaClinical Lymphoma, Myeloma & Leukemia|August 2, 2017
The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative NeoplasmsBrittany Knick Ragon, Michael R SavonaPageof 16